These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29242073)

  • 21. Post-marketing surveillance: adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries.
    Overbosch D
    J Travel Med; 2003 May; 10 Suppl 1():S16-20; discussion S21-3. PubMed ID: 12737756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drugs for preventing malaria in travellers.
    Jacquerioz FA; Croft AM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006491. PubMed ID: 19821371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children.
    Lell B; Luckner D; Ndjavé M; Scott T; Kremsner PG
    Lancet; 1998 Mar; 351(9104):709-13. PubMed ID: 9504515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
    Camus D; Djossou F; Schilthuis HJ; Høgh B; Dutoit E; Malvy D; Roskell NS; Hedgley C; De Boever EH; Miller GB;
    Clin Infect Dis; 2004 Jun; 38(12):1716-23. PubMed ID: 15227617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
    Blanshard A; Hine P
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults.
    Petersen E
    J Travel Med; 2003 May; 10 Suppl 1():S13-5; discussion S21. PubMed ID: 12737755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of atovaquone-proguanil during pregnancy.
    Mayer RC; Tan KR; Gutman JR
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30544231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [symbol: see text] Atovaquone + proguanil for malaria prophylaxis.
    Drug Ther Bull; 2001 Oct; 39(10):73-5. PubMed ID: 11706518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria.
    Nakato H; Vivancos R; Hunter PR
    J Antimicrob Chemother; 2007 Nov; 60(5):929-36. PubMed ID: 17848375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
    J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptoms of illness during travel and risk factors for non-adherence to malaria prophylaxis-a cross-sectional study in travellers from Germany.
    Reinsberg F; Moehlmann MW; Krumkamp R; Landsmann L; Heitkamp C; Jochum J; Addo M; Ramharter M; Radt C; Rothe C; Vinnemeier C; Kreuels B
    J Travel Med; 2023 May; 30(3):. PubMed ID: 37098163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of atovaquone-proguanil malaria chemoprophylaxis in a traveler to Ghana.
    Boggild AK; Lau R; Reynaud D; Kain KC; Gerson M
    Travel Med Infect Dis; 2015; 13(1):89-93. PubMed ID: 25582377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Malaria chemoprophylaxis].
    Petersen JE
    Ugeskr Laeger; 2005 Oct; 167(42):3984-7. PubMed ID: 16232397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.
    Mavrogordato A; Lever AM
    J Infect; 2012 Sep; 65(3):269-74. PubMed ID: 22609735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacology of atovaquone and proguanil hydrochloride.
    Beerahee M
    J Travel Med; 1999 May; 6 Suppl 1():S13-7. PubMed ID: 23573547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
    Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of atovaquone and proguanil hydrochloride for the prophylaxis of Plasmodium falciparum malaria in South Africa.
    van der Berg JD; Duvenage CS; Roskell NS; Scott TR
    Clin Ther; 1999 Apr; 21(4):741-9. PubMed ID: 10363739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of atovaquone/proguanil to prevent Plasmodium ovale malaria in traveler returning from Cameroon.
    Gallien S; Taieb F; Schlemmer F; Lagrange-Xelot M; Atlan A; Sarfati C; Molina JM
    Travel Med Infect Dis; 2008 May; 6(3):128-9. PubMed ID: 18486067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.
    Looareesuwan S; Chulay JD; Canfield CJ; Hutchinson DB
    Am J Trop Med Hyg; 1999 Apr; 60(4):533-41. PubMed ID: 10348225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.